After A 23% Slide, Is TMDX Stock Worth A Look?

TMDX: TransMedics logo
TMDX
TransMedics

TransMedics stock has fallen by 22.7% in less than a month, from levels of $134.01 on 6/30/2025 to $103.61 now. Should you buy this dip? Dip buying is a viable strategy for quality stocks that have a history of recovering from dips.

As it turns out, TransMedics passes basic quality checks and has returned (median) 147% in one year, and 182% as peak return following sharp dips (>30% in 30 days) historically.

That said, if you seek upside with lower volatility than individual stocks, the Trefis High Quality portfolio presents an alternative – having outperformed the S&P 500 and generated returns exceeding 91% since its inception.

Historical Median Returns Post Dips

Relevant Articles
  1. Get Paid 8.5% to Buy NFLX at a 30% Discount – Here’s How
  2. What Could Send Broadcom Stock Soaring
  3. Cisco Systems Stock Can Sink, Here Is How
  4. Coeur Mining Stock’s Winning Streak May Not Be Over Yet
  5. Is Wall Street Underestimating PayPal Stock’s Potential?
  6. Intuitive Machines Stock To $10?

Period Past Median Return
1M -11.6%
3M 10.6%
6M 18.4%
12M 146.9%

Historical Dip-Wise Details

TMDX had 5 events since 1/1/2020 where the dip threshold of -30% within 30 days was triggered

  • 182% median peak return within 1 year of dip event
  • 350 days is the median time to peak return after a dip event
  • -39% median max drawdown within 1 year of dip event

30 Day Dip TMDX Subsequent Performance
Date TMDX SPY 1Y Peak
Return
Max
Drop
# Days
to Peak
Median     147% 182% -39% 350
10292024 -43% 4% 17% 62% -36% 226
8242023 -31% -3% 173% 182% -41% 365
12172021 -34% -1% 168% 211% -39% 350
4272021 -32% 6% -29% 18% -57% 73
3092020 -31% -17% 147% 187% -24% 358

TransMedics Passes Basic Financial Quality Checks

Revenue growth, profitability, cash flow, and balance sheet strength need to be evaluated to reduce the risk of a dip being the sign of a deteriorating business situation.

Quality Metrics Value Quality Check
Revenue Growth (LTM) 64.4% Pass
Revenue Growth (3-Yr Avg) 139.5% Pass
Operating Cash Flow Margin (LTM) 10.1% Pass
Leverage (see below) Pass
=> Interest Coverage Ratio 4.5  
=> Cash To Interest Expense Ratio 21.7  

Dip buying, while attractive, needs to be evaluated carefully from multiple angles. Such multi-factor analysis is exactly how we construct Trefis portfolio strategies. If you want upside with a smoother ride than an individual stock, consider the High Quality portfolio, which has outperformed the S&P, and clocked >91% returns since inception.